Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: A systematic review of non-randomized studies
暂无分享,去创建一个
T. Agoritsas | J. Busse | D. Zeraatkar | R. Couban | B. Hong | M. Cooper | P. Hong | K. Loniewski | J. Dookie | G. Leung | C. Hong | A. Agarwal | M. Ahmed | R. Vernooij | D. Zeraatkar
[1] R. Day,et al. Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis , 2021, Systematic Reviews.
[2] D. Nutt,et al. The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms , 2020, European Neuropsychopharmacology.
[3] F. Salaffi,et al. Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. , 2020, Clinical and experimental rheumatology.
[4] E. Ostardo,et al. Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome , 2019, BioMed research international.
[5] G. Guyatt,et al. GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions. , 2019, Journal of clinical epidemiology.
[6] J. Abbott,et al. Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey. , 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[7] Y. Ringel,et al. Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. , 2019, European journal of gastroenterology & hepatology.
[8] K. Broich,et al. [Cannabis medicines in pain management : Interim analysis of the survey accompanying the prescription of cannabis-based medicines in Germany with regard to pain as primarily treated symptom]. , 2019, Schmerz.
[9] K. Richter,et al. A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2016-2017 , 2019, JAMA network open.
[10] A. Paoletti,et al. Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study , 2019, International journal of women's health.
[11] Blair H Smith,et al. Chronic pain: a review of its epidemiology and associated factors in population-based studies. , 2019, British journal of anaesthesia.
[12] V. Novack,et al. Safety and Efficacy of Medical Cannabis in Fibromyalgia , 2019, Journal of clinical medicine.
[13] M. Ueberall,et al. Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry , 2019, Journal of pain research.
[14] P. Di Patrizio,et al. Dronabinol use in France between 2004 and 2017. , 2019, Revue neurologique.
[15] D. Zylla,et al. Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota's Medical Cannabis Program. , 2019, Journal of oncology practice.
[16] M. Walton,et al. Driving under the influence of cannabis among medical cannabis patients with chronic pain. , 2019, Drug and alcohol dependence.
[17] M. Ilgen,et al. Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain. , 2019, Drug and alcohol dependence.
[18] M. Schatman,et al. Cannabis for Chronic Pain: Not Ready for Prime Time. , 2019, American journal of public health.
[19] L. Degenhardt,et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies , 2018, Pain.
[20] Sieta T. de Vries,et al. Self-Reported Effectiveness and Safety of Trokie® Lozenges: A Standardized Formulation for the Buccal Delivery of Cannabis Extracts , 2018, Front. Neurosci..
[21] E. Spackman,et al. The adverse health effects and harms related to marijuana use: an overview review. , 2018, CMAJ open.
[22] D. Kansagara,et al. The Effects of Cannabis Among Adults With Chronic Pain , 2018, Annals of Internal Medicine.
[23] G. Habib,et al. Medical Cannabis for the Treatment of Fibromyalgia , 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[24] G. Guyatt,et al. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. , 2018, Journal of clinical epidemiology.
[25] G. M. Allan,et al. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms. , 2018, Canadian family physician Medecin de famille canadien.
[26] M. Fiore,et al. The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms , 2017, BMC Anesthesiology.
[27] Jacob M. Vigil,et al. Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study , 2017, PloS one.
[28] J. Arnedt,et al. Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain. , 2017, Drug and alcohol dependence.
[29] V. G. Lappi,et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. , 2017, The Cochrane database of systematic reviews.
[30] S. Schimrigk,et al. Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients , 2017, European Neurology.
[31] A. Paladini,et al. Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome , 2017, Pain research and treatment.
[32] M. Bhandari,et al. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials , 2017, PLoS medicine.
[33] M. Schatman,et al. Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients , 2017, Journal of pain research.
[34] Joseph W. Frank,et al. Guideline for opioid therapy and chronic noncancer pain , 2017, Canadian Medical Association Journal.
[35] S. Haroutounian,et al. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study , 2016, The Clinical journal of pain.
[36] M. Hernán,et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.
[37] Gordon H Guyatt,et al. Introduction to BMJ Rapid Recommendations , 2016, British Medical Journal.
[38] I. Goor-Aryeh,et al. Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain , 2016, Pain medicine.
[39] M. Large,et al. Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use , 2016, The Australian and New Zealand journal of psychiatry.
[40] David Moher,et al. PRISMA harms checklist: improving harms reporting in systematic reviews , 2016, British Medical Journal.
[41] J. Collet,et al. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). , 2015, The journal of pain : official journal of the American Pain Society.
[42] K. Hill,et al. Low to moderate quality evidence demonstrates the potential benefits and adverse events of cannabinoids for certain medical indications , 2015, Evidence-Based Medicine.
[43] S. Skaper,et al. Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies , 2015, Pain and Therapy.
[44] A. Deshpande,et al. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials. , 2015, Canadian family physician Medecin de famille canadien.
[45] Penny F Whiting,et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.
[46] G. Guyatt,et al. Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop , 2015, The Journal of Rheumatology.
[47] A. Lacasse,et al. Cannabis in medicine: a national educational needs assessment among Canadian physicians , 2015, BMC medical education.
[48] C. Leotta,et al. Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients , 2014, Pain research and treatment.
[49] G. Kaplan,et al. Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohn's Disease , 2014, Inflammatory bowel diseases.
[50] L. Korngut,et al. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain , 2012, PAIN®.
[51] A. Sabato,et al. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. , 2012, Pain medicine.
[52] A. D. Martin,et al. N-palmitoylethanolamide in the treatment of neuropathic pain associated with lumbosciatica. , 2012, Pain management.
[53] C. Toth,et al. An Open‐Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy , 2011, Pain practice : the official journal of World Institute of Pain.
[54] M. Farré,et al. Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life , 2011, PloS one.
[55] Xin Sun,et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.
[56] C. Konrad,et al. Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey , 2009, Anesthesiology research and practice.
[57] J. Collet,et al. Adverse effects of medical cannabinoids: a systematic review , 2008, Canadian Medical Association Journal.
[58] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[59] T. Nurmikko,et al. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. , 2007, Clinical therapeutics.
[60] A. J. Clark,et al. A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations. , 2006, Journal of pain and symptom management.
[61] W. Katon,et al. Depression and pain comorbidity: a literature review. , 2003, Archives of internal medicine.
[62] A. J. Clark,et al. Cannabis use for chronic non-cancer pain: results of a prospective survey , 2003, Pain.
[63] K. Wilson,et al. Major Depression and Insomnia in Chronic Pain , 2002, The Clinical journal of pain.
[64] P. McGrath,et al. The epidemiology of pain in children and adolescents: a review , 1991, Pain.
[65] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[66] J. Tukey,et al. Transformations Related to the Angular and the Square Root , 1950 .
[67] D. Robinson,et al. Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. , 2019, Clinical and experimental rheumatology.
[68] F. Signorelli,et al. Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): A series of 100 cases. , 2018, Neurologia i neurochirurgia polska.
[69] J. Hovorka,et al. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain , 2014, Journal of Neurology.
[70] Rhonda J. Moore. Handbook of Pain and Palliative Care , 2013 .
[71] M. Kahan,et al. Is there a role for marijuana in medical practice? No. , 2007, Canadian family physician Medecin de famille canadien.
[72] M. Ware. Is there a role for marijuana in medical practice? Yes. , 2007, Canadian family physician Medecin de famille canadien.